Silverback Therapeutics shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $458k | 43k | 10.55 |
| 2024-09-30 | $417k | 29k | 14.50 |
| 2024-06-30 | $177k | 21k | 8.51 |
| 2024-03-31 | $151k | 15k | 10.22 |
| 2023-12-31 | $84k | 15k | 5.48 |
| 2022-03-31 | $39k | 11k | 3.50 |
| 2021-12-31 | $83k | 13k | 6.66 |
| 2021-09-30 | $118k | 12k | 10.00 |
| 2021-06-30 | $239k | 7.7k | 30.87 |
| 2021-03-31 | $536k | 12k | 43.48 |
| 2020-12-31 | $232k | 5.0k | 46.40 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft